INS and Hyperglycemia: In our dataset the pharmacological treatment of hyperglycemia seemed to be tailored to phenotypic characteristics of patients, and subjects with FLI ≥ 60, who had higher BMI and waist circumference, were more frequently treated with insulin sensitizers (metformin and particularly thiazolidinediones, that could improve the evolution of NAFLD) and less frequently with insulin and sulphonamides, as compared to patients with FLI < 30.